# Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease

> **NCT02681978** · PHASE4 · COMPLETED · sponsor: **Campus Bio-Medico University** · enrollment: 70 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Standard medical therapy

## Key facts

- **NCT ID:** NCT02681978
- **Lead sponsor:** Campus Bio-Medico University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02681978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02681978, "Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02681978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*